Clinical Ink Revenue and Competitors
Estimated Revenue & Valuation
- Clinical Ink's estimated annual revenue is currently $66.6M per year.
- Clinical Ink received $Undisclosed in venture funding in May 2018.
- Clinical Ink's estimated revenue per employee is $251,250
- Clinical Ink's total funding is $35M.
Employee Data
- Clinical Ink has 265 Employees.
- Clinical Ink grew their employee count by 0% last year.
Clinical Ink Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.8M | 29 | 4% | N/A | N/A |
#2 | $3.2M | 16 | 0% | N/A | N/A |
#3 | $83.2M | 414 | 7% | N/A | N/A |
#4 | $31M | 154 | 56% | N/A | N/A |
#5 | $66.6M | 265 | 0% | $35M | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -6% | N/A | N/A |
#8 | $165.7M | 216 | 14% | $250.7M | N/A |
#9 | $26.5M | 132 | -11% | $637.8K | N/A |
#10 | $49.4M | 246 | 6% | N/A | N/A |
What Is Clinical Ink?
Clinical Ink is the leading provider of eSource solutions for the global clinical trials market. Founded in 2007, Clinical Ink® is transforming clinical development with innovative technologies that make clinical research easier for sites, sponsors and patients. Clinical Ink's SureSource® platform directly captures eSource data and documents and improves patient engagement while streamlining clinical development. Clinical Ink maintains offices in Winston-Salem, NC, and Philadelphia, PA. Find more at www.clinicalink.com. Our customer base includes pharmaceutical and medical device companies, academic institutions, and CROs. SureSource has been successfully used in a wide range of therapeutic areas including CNS, infectious diseases, dermatology, gastroenterology, and virology.
keywords:Healthcare,Pharmaceuticals
$35M
Total Funding
265
Number of Employees
$66.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clinical Ink's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President | Reveal Email/Phone |
2 | Project Manager | Reveal Email/Phone |
3 | Outcomes Solutions Sr. Manager, Team Lead | Reveal Email/Phone |
4 | Director, Program Management | Reveal Email/Phone |
5 | Project Manager | Reveal Email/Phone |
6 | Product Manager | Reveal Email/Phone |
7 | Staff Data Specialist | Reveal Email/Phone |
8 | Principal Software Engineer | Reveal Email/Phone |
9 | Project Design Manger at Clinical ink | Reveal Email/Phone |
10 | VP, Business Operations | Reveal Email/Phone |
Clinical Ink News
Horsham, PA, April 11, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, todayWorld Parkinson's...
The Clinical ink team partnered with the University of Rochester and two bio-pharmaceutical companies on WATCH-PD to explore the viability of consumer grade...
Several reputable vendors offer holistic eSource solutions. But what if you want to build and operationalize studies yourself? TORONTO (PRWEB) June 22, 2021 With increased attention on decentralized clinical trials, a growing number of sponsors and CROs plan to adopt direct data capture (DDC), ...
Since smartphones are central to patients’ lives, incorporating them into clinical trials is a logical step toward more reliable and less burdensome electronic patient-reported outcomes (ePRO) collection. TORONTO (PRWEB) March 18, 2021 While bring-your-own-device (BYOD) has been in use for yea ...
"With technology platforms like elluminate, we can build on the industry-wide advances made during the pandemic, help manage the data streams coming from decentralized trials and deliver new and important treatments to patients," said Raj Indupuri, Co-Founder and CEO of eClinical Solutions. MAN ...
Other Companies in Winston-Salem
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $52.7M | 266 | N/A | N/A |
#2 | $87.7M | 275 | 5% | N/A |
#3 | $15M | 309 | 4% | N/A |
#4 | $90.8M | 320 | 10% | N/A |
#5 | $88.8M | 323 | 5% | N/A |
Clinical Ink Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2013-10-17 | $4.3M | B | FCA Venture Partners | Article |
| 2015-03-19 | $Undisclosed | Undisclosed | MPM Capital | Article |
| 2018-05-15 | $Undisclosed | Undisclosed | RTI International | Article |
Clinical Ink Executives
| Name | Title |
|---|---|
| Brian Donahue | Chief Operating Officer |
| Chris Crucitti | Chief Commercial Officer |
| Ed Seguine | CEO |
| Scott Miltenberger | Chief Financial Officer |
| Vikram Natarajan | Chief Technology Officer |
| Janette Morgan | EVP, General Manager, EMEA |
| Doug Pierce | President |
| George Slavish | Vice President, Business Operations |
| John Pappadakis | Vice President, Global Business Development |
| Megan Petrylak | Vice President, Strategic Delivery |
| Brian Olson | Vice President - Development Services |
| Son Nly | VP, Data Services |
| Nick Starn | Vice President, Customer Operations |
| Janette Morgan | EVP, EMEA & Global Head of Commercial Operations |
| Brian Olson | Vice President - Development Services |
| Bill Barasso | Vice President, Project Operations |
| Chris Valas | Executive Vice President, Engineering |
| Maureen Cleveland | Vice President of Customer Operations |
| Son Ly | Vice President, Data Services |